Deadly avalanche claims one victim – how researchers are using computer models to improve warnings – The Rocky Mountain Goat Computer
Eli Lilly Alzheimer’s drug setback extends rival Biogen’s lead – analystsBy Publishing TeamJanuary 20, 2023 Jan 20 (Reuters) – U.S. health regulator’s rejection of fast-track approval of Eli Lilly and Co’s Alzheimer’s drug extends market…
Eisai and Biogen’s Alzheimer’s drug price not expected to depress demand, analysts sayBy Publishing TeamJanuary 15, 2023 Jan 9 (Reuters) – The $26,500-a-year price for Eisai Co Ltd (4523.T) and Biogen Inc’s recently approved Alzheimer’s disease drug…
